Clostridium difficile infection in cancer patients and hematopoietic stem cell transplant recipients.
about
WSES guidelines for management of Clostridium difficile infection in surgical patientsBacterial Infections in Hematopoietic Stem Cell Transplant RecipientsClostridium difficile Infection in Special High-Risk PopulationsDiversity and Evolution in the Genome of Clostridium difficileClostridium difficile Infections amongst Patients with Haematological Malignancies: A Data Linkage StudyTryptophan catabolism restricts IFN-γ-expressing neutrophils and Clostridium difficile immunopathologyEpidemiology of Clostridium difficile infectionImpact of toxigenic Clostridium difficile colonization and infection among hospitalized adults at a district hospital in southern Taiwan.Clostridium difficile-associated diarrhea in radiooncology: an underestimated problem for the feasibility of the radiooncological treatment?Clostridium difficile carriage in hospitalized cancer patients: a prospective investigation in eastern China.Clostridium difficile: improving the prevention paradigm in healthcare settings.Environmental transmission of Clostridium difficile: association between hospital room size and C. difficile InfectionRisk factors for recurrent hospital-acquired Clostridium difficile infection in a Japanese university hospital.Innate Immune Defenses Mediated by Two ILC Subsets Are Critical for Protection against Acute Clostridium difficile Infection.Evaluating risk factors for Clostridium difficile infection in adult and pediatric hematopoietic cell transplant recipientsDiagnosis of Clostridium difficile infection: an ongoing conundrum for clinicians and for clinical laboratories.Clostridium difficile colonization in preoperative colorectal cancer patients.Management of gram-positive bacterial infections in patients with cancer.Antimicrobial stewardship in patients with cancer.The epidemiology of Clostridium difficile infection in patients with cancer.Role of Dietary Metabolites in Regulating the Host Immune Response in Gastrointestinal Disease.Role of the leukocyte response in normal and immunocompromised host after Clostridium difficile infection.Risk factors and epidemiology of Clostridium difficile infection in hematopoietic stem cell transplant recipients during the peritransplant period.Bacterial infections in pediatric hematopoietic stem cell transplantation recipients: incidence, epidemiology, and spectrum of pathogens: report of the Polish Pediatric Group for Hematopoietic Stem Cell Transplantation.Impact of malignancy on Clostridium difficile infection.Ipilimumab-associated colitis or refractory Clostridium difficile infection?Risk factors associated with Clostridium difficile infection in adult oncology patients.Predictors of mortality attributable to Clostridium difficile infection in patients with underlying malignancy.Chemotherapy patients with C. difficile colitis have outcomes similar to immunocompetent C. difficile patients.Prevalence of Clostridium Difficile Infection in Patients After Radical Cystectomy and Neoadjuvant Chemotherapy.Management of Recurrent Clostridium difficile Infection During Intensive Chemotherapy and Stem Cell Transplantation for Leukemia: Case with Literature Review.A Retrospective Study Analyzing the Appropriateness of Initial Treatment of Clostridium difficile in Patients with Active Malignancy.
P2860
Q26795429-A263E9A8-99DB-4A3A-A634-FF7E9041FE19Q26799576-6CA74B52-15A6-4264-A520-C009C3E080C7Q28069414-633C18E5-DDB3-4681-A2C7-067E81657084Q28084700-C4978A8E-3FB3-47E7-BD1C-8DA40E2E9EA4Q31108764-1AD55775-B374-4042-A1E0-22BFCBC784DEQ33880455-502C901C-1990-4A5D-9674-6213CB3F43D8Q34027474-E6FCDD65-F5B2-4E91-ACFA-C12444BDCA04Q34372612-62042583-72E6-4ED8-A86E-51A5EDEF20B9Q34631324-9E9F5199-DA18-41C7-9186-C00EF277EB52Q34667674-FD190B3A-7244-4505-A023-B205F3813562Q35222472-30E373BE-F97C-4811-A091-AB2BAF1A431BQ35471522-A99482CE-AB70-42F1-AE85-C601B916E6AEQ35866318-490ADB17-1074-4856-9980-CB5E052D6E0BQ35957398-8C31B73C-2A07-4DCB-927F-8021976ED464Q36164920-5AFA21C8-A03F-4C0D-A625-04F77F94B717Q37035829-A254DC9E-9314-42B3-B234-EA17E3161876Q37707006-40B84BD9-8BFA-4285-844D-FA0E78E4B1B3Q37899198-62F32519-EC8C-4305-AB44-CB71ECC0E47EQ38073198-0D17F8BF-ECB5-494A-92E0-36BBFB348940Q38823326-51FFB2C4-D219-4759-B656-99FC672325A4Q39132612-B55E9341-129B-40BC-B82A-9FEB2A5D4223Q39145792-EF186A73-C731-47AF-9E1C-B340546E0D97Q40413411-E2A6C290-760B-42DF-A8D8-0192220807D2Q40593048-E8A05B27-DA41-4D71-A1E0-771BB4102253Q40598769-A7F15A89-5B8A-48E3-98F8-C55588813CDBQ41110062-C8DD9500-8B63-4B7E-99A9-5801E06BEA90Q41655888-09EC0B1D-21F3-4F02-B113-C92529043A26Q42225665-BE73F7CE-6B42-4534-A8FB-42F153033437Q44356314-BCDD13FE-497B-4330-8D1D-387C74ECDC13Q45410645-F10FAF9B-BA74-45DB-9E48-C50495684F50Q55000776-9AE1378C-2C5A-494E-9CDF-399DAA6A4074Q55476382-08D79A98-795C-4B2B-BE07-264BF1CA9831
P2860
Clostridium difficile infection in cancer patients and hematopoietic stem cell transplant recipients.
description
2010 nî lūn-bûn
@nan
2010 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
name
Clostridium difficile infectio ...... em cell transplant recipients.
@ast
Clostridium difficile infectio ...... em cell transplant recipients.
@en
Clostridium difficile infectio ...... em cell transplant recipients.
@nl
type
label
Clostridium difficile infectio ...... em cell transplant recipients.
@ast
Clostridium difficile infectio ...... em cell transplant recipients.
@en
Clostridium difficile infectio ...... em cell transplant recipients.
@nl
prefLabel
Clostridium difficile infectio ...... em cell transplant recipients.
@ast
Clostridium difficile infectio ...... em cell transplant recipients.
@en
Clostridium difficile infectio ...... em cell transplant recipients.
@nl
P2093
P2860
P356
P1476
Clostridium difficile infectio ...... em cell transplant recipients.
@en
P2093
George J Alangaden
Pranatharthi Chandrasekar
Teena Chopra
P2860
P304
P356
10.1586/ERI.10.95
P577
2010-10-01T00:00:00Z